Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation
- 31 July 2002
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 16 (8) , 1460-1469
- https://doi.org/10.1038/sj.leu.2402584
Abstract
Leukemia is one of the leading journals in hematology and oncology. It is published monthly and covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance.Keywords
This publication has 23 references indexed in Scilit:
- Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratificationBlood, 2001
- Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2000
- Current therapy for CLLHematology and Cell Therapy, 2000
- Immunophenotypical detection of minimal residual disease in acute leukemiaCritical Reviews in Oncology/Hematology, 1999
- Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALLLeukemia, 1999
- Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1998
- Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemiaThe Lancet, 1998
- Bone marrow transplantation for low-grade B-cell malignanciesCurrent Opinion in Oncology, 1997
- Characterization of aberrant phenotypes in acute myeloblastic leukemiaAnnals of Hematology, 1995
- Acute Lymphoblastic Leukemia (ALL): Detection of Minimal Residual Disease (MRD) at Flow CytometryLeukemia & Lymphoma, 1994